Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-03 Sale |
2025-01-07 8:05 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
4,875 | $16.78 | $81,790 | 62,258 (Direct) |
View |
| 2024-12-09 Sale |
2024-12-11 4:28 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
13,664 | $25.26 | $345,134 | 212,132 (Direct) |
View |
| 2024-11-19 Sale |
2024-11-21 6:52 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
38,689 | $16.78 | $649,030 | 400,600 (Direct) |
View |
| 2024-11-14 Sale |
2024-11-18 7:32 pm |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
82,368 | $17.46 | $1,438,038 | 536,257 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-06 4:19 pm |
N/A 2035-01-01 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
63,500 | $0 | 114,533 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-11 4:28 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
13,664 | $0 | 212,132 (Direct) |
View |
| 2024-12-09 Exercise |
2024-12-11 4:28 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
13,664 | $1.41 | 212,132 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-21 6:52 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
38,689 | $0 | 400,600 (Direct) |
View |
| 2024-11-19 Exercise |
2024-11-21 6:52 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
38,689 | $1.41 | 400,600 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:32 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
82,368 | $0 | 536,257 (Direct) |
View |
| 2024-11-14 Exercise |
2024-11-18 7:32 pm |
N/A N/A |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
82,368 | $1.41 | 536,257 (Direct) |
View |
| 2024-04-08 Exercise |
2024-04-10 9:30 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer |
249,598 | $0 | 358,860 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 5:03 pm |
N/A 2034-01-01 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Operating Officer |
3,496,000 | $0 | 3,496,000 (Direct) |
View |
| 2023-11-13 Option Award |
2023-11-15 4:42 pm |
N/A 2026-11-06 |
Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Operations Officer |
7,270 | $0 | 7,270 (Direct) |
View |